Across TCGA pan-cancer cohorts, SNORD115-23 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated SNORD115-23 data layer compared with 1 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SNORD115-23 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD115-23 expression acts as an unfavorable survival marker.
UCEC and BLCA are the cancer types where SNORD115-23 RNA most reproducibly stratifies survival.